Sysmex Canada introduces new hematology analyzers

Sysmex Canada, providers of automated hematology and urinalysis diagnostic testing, has launched the new XN-L Series for testing in smaller analytic devices.

The XN-L is designed for smaller healthcare organizations that do not need the larger XN-Series analyzer, making the system affordable while still maintaining quality results. The system integrates with laboratories that require a high quality backup.

"We are pleased to be able to offer the XN-L Series of hematology analyzers to the Canadian healthcare market," said Carl Rocha, general manager at Sysmex. "The XN-L Series complements our flagship XN-Series analyzers by serving the lower volume end of the healthcare spectrum. The XN-L can also serve as a high-quality backup for larger labs, especially those with an XN-Series analyzer, offering standardization of reagents and controls across all test volume segments."

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”